Coeptis Therapeutics Inc.
COEPDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819663
Coeptis Therapeutics Inc. was delisted in 2022; its insiders filed their last Form 4 on Nov 18, 2021; no institution reported holding it in 13F filings for Q3 2022; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Coeptis Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Coeptis Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mehalick David | CEO and President | 1,800,000 | Nov 18, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Mehalick DavidCEO and President | SSale | −1.20M | – | – | −40.0%1.80M after |